This compound is a quinazoline derivative used as a pharmaceutical intermediate in drug synthesis. It features a halogenated aromatic ring system with ether substituents, commonly employed in the manufacturing of active pharmaceutical ingredients.
Alcance del contenido: La información de esta página se refiere a la identificación química y a los contextos de suministro industrial, investigación y producción. No constituye una afirmación terapéutica, un consejo médico ni instrucciones de uso de medicamentos.
¿Adquiriendo o suministrando este compuesto?
Publique su inventario o una solicitud de compra
CAS 183322-21-6
3-Bromofuran
pharmaceutical intermediate for drug synthesis
2,4,6-Trichloropyrimidin-5-amine
pharmaceutical intermediate for drug synthesis
(Z)-3-(3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)acrylic acid
pharmaceutical intermediate for drug synthesis
N-[5-(4-Bromophenyl)-6-chloro-4-pyrimidinyl]-N'-propylsulfamide
pharmaceutical intermediate for drug synthesis
Bdh succinate
Pharmaceutical intermediate for HIV protease inhibitors
4,6-diamino-2-chloropyrimidine-5-carbonitrile
pharmaceutical intermediate
6-amino-5-methylnicotinonitrile
Pharmaceutical intermediate
5-Bromo-2-iodopyrimidine
Pharmaceutical intermediate
4-chloro-6,7-bis(2-chloroethoxy)quinazoline
WXAZLCUYDRYLFC-UHFFFAOYSA-N
C1=C2C(=CC(=C1OCCCl)OCCCl)N=CN=C2Cl